Acute interstitial nephritis with severe acute renal failure is reported following tetracycline treatment in a 22-year-old male medical student. Acute renal failure developed within 48 h of a single repeated tetracycline dose and presented 2 days after taking the drug when there was oliguria, nausea, vomiting and bilateral loin pain without rash and fever. The serum creatinine concentration was 8.6 mg/dl and blood urea nitrogen 84 mg/dl. Examination of the urinary sediment revealed 15–20 RBCs per high-power field, and occasional granular and hyaline casts. Percutaneous renal biopsy performed immediately after admission revealed acute interstitial nephritis with immune complexes along the tubular basement membrane and intact glomeruli and was consistent with type 2 interstitial nephritis. Within 4 days of commencement of steroid treatment and hemodialysis, the urine output started to increase with improvement in serum creatinine and BUN levels and after 2 weeks of therapy hemodialysis was discontinued. He remains well 1 year following his illness with complete normalization of his renal function. Although a number of renal side effects of tetracycline antibiotics have been reported, acute interstitial nephritis is rarely caused by tetracycline treatment having been reported just twice following systemic use of minocycline.

Brenner BM, Rector FC Jr: The Kidney. Philadelphia, Saunders, 1991, vol 2, pp. 1430–1497.
Clausen G, Nagy Z, Szalay L, Aukland K: Mechanisms in acute oliguric renal failure induced by tetracycline infusion. Scand J Clin Lab Invest 1975;35:625–633.
Lew HT, French SW: Tetracycline nephrotoxicity and non-oliguric acute renal failure. Arch Intern Med 1966;118:123–128.
Walker RG, Thomson NM, Dowling JP, Ogg CS: Minocycline-induced acute interstitial nephritis. Br Med J 1979;i:524.
Wilkinson SP, Stewart WK, Spiers EM, Pears J: Protracted systemic illness and interstitial nephritis due to minocycline. Postgrad Med J 1989;65:53–56.
Hill GW, Roach M: Minocycline-induced interstitial nephritis. Br Med J 1979;i:820–821.
Neilson EG: Nephrology Forum: Pathogenesis and therapy of interstitial nephritis. Kidney Int 1989;35:1257–1270.
Van Ypersele de Strihou: Nephrology forum: Acute oliguric interstitial nephritis. Kidney Int 1979;16:751–765.
Murray KM, Keane WR: Review of drug-induced acute interstitial nephritis. Pharmacotherapy 1992;12:462–467.
Kida H, Abe T, Tomosugi N, Koshino Y, Yokoyama H, Hattori N: Prediction of the long-term outcome in acute interstitial nephritis. Clin Nephrol 1984;22:55–60.
Linton AL, Clark WF, Driedger AA, Turnbull I: Acute interstitial nephritis due to drugs. Review of the literature with a report of nine cases. Ann Intern Med 1980;93:735–741.
Landais P: Eosinophiluria and drug-induced acute interstitial nephritis. N Engl J Med 1982;316:1664.
Karras DJ: Severe low back pain secondary to acute interstitial nephritis following administration of ranitidine. Am J Emerg Med 1994;12:67–68.
Koselj M, Kveder R, Bren AF, Rott T: Acute renal failure in patients with drug-induced acute interstitial nephritis. Renal Fail 1993;15:69–72.
Nolan CR, Anger MS, Kelleher SP: Eosinophiluria: A new method of detection and definition of the clinical spectrum. N Engl J Med 1986;315:1516–1519.
Ruffing KA, Hoppes P, Blend D, Cugino A, Jarjoura D, Whittier FC: Eosinophils in urine revisited. Clin Nephrol 1994;41:163–166.
Droz D, Kleinknecht D: Acute interstitial nephritis; in Davison AM, et al (eds): Oxford Textbook of Clinical Nephrology, ed 2. Oxford, Oxford University Press. 1998, vol 2, pp 1634–1644.
Boucher A, Droz D, Adafer E, Noe LH: Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986;29:1043–1049.
Ooi BS, Jao W, First M, Mancilla R, Pollak VE: Acute interstitial nephritis: A clinical and pathological study based on renal biopsies. Am J Med 1975;59:614–628.
Buysen JGM, Houthoff HJ, Krediet RT, Arisz L: Acute interstitial nephritis: A clinical and morphological study in 27 patients. Nephrol Dial Transplant 1990;5:94–99.
Laberke HG, Bohle A: Acute interstitial nephritis: correlation between clinical and morphological findings. Clin Nephrol 1980;14:263–273.
Bhaumik SK, Kher V, Arora P, Rai PK, Singhal M, Gupta A, Pandey R, Sharma RK: Evaluation of clinical and histological prognostic markers in drug-induced acute interstitial nephritis. Renal Fail 1996;18:97–104.
Fletcher S, Sellars L: Minocycline-induced chronic interstitial nephritis? Nephrol Dial Transplant 1996;11:540–541.
Smythe WR, Bavaria JE: Tetracycline pleurodesis-associated acute renal failure. Chest 1993;104:1274–1276.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.